HMGB1 and metabolic dysfunction-associated steatotic liver disease: The redox modification of cysteine residues determines the pro-inflammatory activity of HMGB154, and the generation of lipid peroxidation and ROS which are increased in the pathogenesis of NAFLD1, may partially oxidate HMGB1 and enhance its pro-inflammatory activity.